Stay updated on NOX66 Safety, PK, Efficacy in Solid Tumours Clinical Trial

Sign up to get notified when there's something new on the NOX66 Safety, PK, Efficacy in Solid Tumours Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NOX66 Safety, PK, Efficacy in Solid Tumours Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the study evaluating the safety and activity of NOX66 in patients with refractory solid tumors, both as a monotherapy and in combination with carboplatin.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:16.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying requirements such as informed consent, age, health condition, and prior treatments. This change provides more specific information about who can participate in the study, which was previously not provided.
    Difference
    27%
    Check dated 2024-05-22T21:29:43.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:54:51.000Z thumbnail image

Stay in the know with updates to NOX66 Safety, PK, Efficacy in Solid Tumours Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NOX66 Safety, PK, Efficacy in Solid Tumours Clinical Trial page.